Clicky

Author name: systems

Pregnant and postpartum women report elevated depression, anxiety, and post-traumatic stress during COVID-19 pandemic | News

For immediate release: Wednesday, April 21, 2021 Boston, MA – In a worldwide survey, pregnant and postpartum women reported high levels of depression, anxiety, loneliness, and post-traumatic stress during the COVID-19 pandemic, according to researchers at Harvard T.H. Chan School of Public Health. Such high levels of distress may have potential implications for women and

Pregnant and postpartum women report elevated depression, anxiety, and post-traumatic stress during COVID-19 pandemic | News Read More »

Patterns between Depressive Symptomatology and Sleep

Introduction Mood disorders are highly prevalent.1 Of the various mood disorders, depression exhibits the highest recurrence and is characterized by chronicity. In patients with bipolar disorder, depression, rather than mania, comprises a longer duration in the disease course,2 and depressive symptoms have the greatest impact on quality of life.3 Sleep-wake-related disturbances (SWRDs) are strongly correlated

Patterns between Depressive Symptomatology and Sleep Read More »

What We Tell Patients about Depression, and What They Say They Have Been Told

And, yes—we often hear anecdotes concerning patients who tell their current clinician some version of, ‘My psychiatrist said I have a chemical imbalance . . .’ But where is the evidence that this is what patients were actually told? Who has contacted the patient’s psychiatrist, or reviewed his/her case notes, to see if that was

What We Tell Patients about Depression, and What They Say They Have Been Told Read More »

US marks slowest population growth since the Depression

WASHINGTON – U.S. population growth has slowed to the lowest rate since the Great Depression, the Census Bureau said, as Americans continued their march to the South and West and one-time engines of growth, New York and California, lost political influence. Altogether, the U.S. population rose to 331,449,281 last year, the Census Bureau said Monday,

US marks slowest population growth since the Depression Read More »

Novel Combination Therapy for Major Depressive Disorder Gets Priority Review

The Food and Drug Administration (FDA) has granted Priority Review to AXS-05 (dextromethorphan-bupropion; Axsome Therapeutics) for the treatment of major depressive disorder (MDD). AXS-05 consists of dextromethorphan, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, and bupropion, a norepinephrine and dopamine reuptake inhibitor that serves to increase the bioavailability of dextromethorphan. The NDA is supported by data from

Novel Combination Therapy for Major Depressive Disorder Gets Priority Review Read More »

Verily, LivaNova kick off study of nerve stimulation for treatment-resistant depression

With the launch of a new study, Verily and LivaNova are hoping to take the “treatment-resistant” out of treatment-resistant depression. About a year after teaming up to form a research collaboration, the partners have officially kicked off their Uncover study, which will collect a range of daily mental and physical health data from patients who

Verily, LivaNova kick off study of nerve stimulation for treatment-resistant depression Read More »